Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Organon & Co. < Previous 1 2 Next > Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy January 05, 2023 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference December 15, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary December 12, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the Piper Sandler 34th Annual Healthcare Conference November 15, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Third Quarter Ended September 30, 2022 November 03, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022 October 20, 2022 From Organon & Co. Via Business Wire Tickers OGN Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd) August 17, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Second Quarter Ended June 30, 2022 August 04, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate July 28, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022 July 21, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates June 13, 2022 From Organon & Co. Via Business Wire Tickers OGN On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report June 02, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the First Quarter Ended March 31, 2022 May 05, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Report First Quarter Results and Host Conference Call on May 5, 2022 April 21, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV) March 31, 2022 From Organon & Co. Via Business Wire Tickers DARE OGN Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021 February 17, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam February 16, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity February 02, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022 February 01, 2022 From Organon & Co. Via Business Wire Tickers OGN FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate January 05, 2022 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference December 20, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon Completes Acquisition of Forendo Pharma December 13, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference November 22, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon Reports Results for the Third Quarter Ended September 30, 2021 November 11, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon to Acquire Forendo Pharma November 11, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021 October 28, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women October 15, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage October 11, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy September 21, 2021 From Organon & Co. Via Business Wire Tickers OGN Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference September 01, 2021 From Organon & Co. Via Business Wire Tickers OGN < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.